The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy girls. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related decrease
in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms related to this ailment, for example http://tinyurl.com/zj86oxg
sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored
The recent conflicting findings on testosterone treatment prompted Patel and his team to conduct a large systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA have problems with low testosterone, which occurs when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This clarifies somebody's unexpected weight gain, clear aging and decline of energy.
And many women have a knee jerk suspicion that any hormone treatment can raise their risk of breast cancer. However, clinical studies demonstrate that testosterone not only does not increase a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will likely remain the status quo for some time, given the prohibitive cost of running the long term safety studies needed to win completer FDA approval.